Skip to main content

Zimmer’s Persona Knee Implant Clears FDA 510(k)

Zimmer’s Persona Knee Implant Clears FDA 510(k)

Zimmer’s Persona Knee Implant Clears FDA 510(k)

Introduction

Zimmer Biomet Holdings Inc. announced on October 31 that it received FDA 510(k) clearance for the Persona revision knee system used in the revision knee replacement procedures. The purpose of a 510(k) submission is to signify that a device is “substantially equivalent” to a predicate device (one that has been cleared by the FDA or marketed before 1976).  

In the press release, Zimmer Biomet's vice president Todd Davis stated, "the clearance of the Persona revision knee system gives us the ability to provide surgeons with a full-service portfolio for the continuum of knee arthroplasty care, from diagnostic tools, cement spacer technologies to re-implantation solutions. The Persona revision knee system gives surgeons the flexibility to truly tailor an implant solution based on each patient’s unique anatomy for a natural fit and function.”

As of September 2018, there are 260 cases pending against Zimmer for inadequately warning patients and doctors about the adverse effects of the faulty knee implants manufactured by them. NexGen and Persona models of knee implants have been reported to fall out due to loosening of defective screws.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!